Concentric Ring Trajectory Sampling With k‐Space Reordering Enables Assessment of Tissue‐Specific T1 and T2 Relaxation for 2H‐Labeled Substrates in the Human Brain at 7 T
Open Access
- 19 December 2024
- journal article
- research article
- Published by Wiley in NMR in Biomedicine
- Vol. 38 (2) , e5311
Abstract
Deuterium metabolic imaging (DMI) is an emerging Magnetic Resonance technique providing valuable insight into the dynamics of cellular glucose (Glc) metabolism of the human brain in vivo using deuterium‐labeled (2H) glucose as non‐invasive tracer. Reliable concentration estimation of 2H‐Glc and downstream synthesized neurotransmitters glutamate + glutamine (Glx) requires accurate knowledge of relaxation times, but so far tissue‐specific T1 and T2 relaxation times (e.g., in gray and white matter) have not been determined. Such measurements are time‐consuming and particularly challenging in the presence of dynamically changing metabolite levels (e.g. 2H Glc and 2H Glx).This study aimed to assess T1 and T2 relaxation times of deuterated resonances, i.e., water, Glc and Glx in human gray and white matter using inversion recovery and Hahn spin‐echo 2H MRSI (magnetic resonance spectroscopic imaging), respectively, with non‐Cartesian concentric ring trajectory readout (CRT) including specific k‐space reordering at 7 T. The sequence was validated using phantom measurements and all results were compared to unlocalized acquisitions. Thirteen healthy volunteers participated in the study, with 10 of them scanned ~90 min after oral administration of 0.8 g/kg [6,6′‐2H]‐glucose. Significantly different T1 and T2 relaxation was observed between GM and WM for 2H water (T1GM/WM/unlocalized = 358 ± 21/328 ± 12/335 m ± 6 ms, p = 0.01) and 2H Glx (T2GM/WM/unlocalized = 37 ± 2/35 ± 2/33 ± 3 ms, p = 0.02), respectively, consistent with unlocalized acquisitions. No significant regional differences were found for 2H water (T2GM/WM/unlocalized = 36 ± 2/34 ± 2/31 ± 2 ms, p = 0.08), 2H Glc (T1GM/WM/unlocalized = 70 ± 5/73 ± 4/80 ± 5 ms, p = 0.13; T2GM/WM/unlocalized = 36 ± 1/34 ± 2/34 ± 2 ms, p = 0.24) and Glx (T1GM/WM/unlocalized = 172 ± 15/172 ± 12/165 ± 11 ms, p = 1.00).Knowledge of tissue‐specific relaxation times can enhance the accuracy of concentration estimation and metabolic flux rates in future studies, potentially improving our understanding of various brain diseases such as cancer, neurodegenerative diseases or diabetes, which are often linked to impaired glucose metabolism.Keywords
Funding Information
- National Institutes of Health (NIH R01EB031787)
- Austrian Science Fund (WEAVE I 6037, & KLI 1106)
- Christian Doppler Forschungsgesellschaft
- European Commission (101088351)
This publication has 40 references indexed in Scilit:
- Sugar for the brain: the role of glucose in physiological and pathological brain functionTrends in Neurosciences, 2013
- Denoising MR Spectroscopic Imaging Data With Low-Rank ApproximationsIEEE Transactions on Biomedical Engineering, 2013
- FSLNeuroImage, 2012
- Impaired mitochondrial function in psychiatric disordersNature Reviews Neuroscience, 2012
- Otto Warburg's contributions to current concepts of cancer metabolismNature Reviews Cancer, 2011
- Comparison of T1 and T2 metabolite relaxation times in glioma and normal brain at 3TJournal of Magnetic Resonance Imaging, 2008
- Sparse MRI: The application of compressed sensing for rapid MR imagingMagnetic Resonance in Medicine, 2007
- k‐t BLAST and k‐t SENSE: Dynamic MRI with high frame rate exploiting spatiotemporal correlationsMagnetic Resonance in Medicine, 2003
- Improved Method for Accurate and Efficient Quantification of MRS Data with Use of Prior KnowledgeJournal of Magnetic Resonance, 1997
- In vivo solvent-suppressed localized hydrogen nuclear magnetic resonance spectroscopy: a window to metabolism?Proceedings of the National Academy of Sciences, 1985